Patrick Bach

Patrick Bach

Auto-generated profile, based on publicly available information

Patrick Bach

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Biological Psychiatry
Verified
Journal Article
Closed access
SVSabine Vollstädt-Klein
Sabine Vollstädt-Klein
SLSabine Loeber
Sabine Loeber
MKMartina Kirsch
Martina Kirsch
PBPatrick Bach
Patrick Bach
ARAnne Richter
Anne Richter
FKFalk Kiefer
Falk Kiefer

25 July 2011 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
SVSabine Vollstädt‐Klein
Sabine Vollstädt‐Klein
SLSabine Loeber
Sabine Loeber
ARAnne Richter
Anne Richter
MKMartina Kirsch
Martina Kirsch
PBPatrick Bach
Patrick Bach
FKFalk Kiefer
Falk Kiefer

1 May 2012 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
CVChristian Vollmert
Christian Vollmert
MGMartin Grosshans
Martin Grosshans
SVSabine Vollstädt-Klein
Sabine Vollstädt-Klein
HTHeike Tost
Heike Tost
SLSaskia Leber
Saskia Leber
FKFalk Kiefer
Falk Kiefer
Obesity is a very expensive health problem that is growing more prevalent every year.1-3 One of the major difficulties with treating obesity is that, even after successful diets, most patients relapse into their previous unhealthy eating habits, thereby regaining most, if not all, of their initial weight.4 The specific neural pathways and mechanisms underlying this excessive calorie consumption are not completely understood.5 While the influences of genetic predisposition6,7 and environmental factors8 of obesity are well known, a clearer understanding of neuronal mechanisms that interact with metabolic regulation is needed to better facilitate the prevention and treatment of obesity.

12 February 2019 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
PBPatrick Bach
Patrick Bach
GWGeorg Weil
Georg Weil
EPEnrico Pompili
Enrico Pompili
SHSabine Hoffmann
Sabine Hoffmann
DHDerik Hermann
Derik Hermann
WSWolfgang H. Sommer
Wolfgang H. Sommer

8 February 2023 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
PBPatrick Bach
Patrick Bach
MLMathias Luderer
Mathias Luderer
UMUlf Joachim Müller
Ulf Joachim Müller
MJMartin Jakobs
Martin Jakobs
JBJuan Carlos Baldermann
Juan Carlos Baldermann
KMKarl Mann
Karl Mann
Treatment resistance in alcohol use disorders (AUD) is a major problem for affected individuals and for society. In the search of new treatment options, few case studies using deep brain stimulation (DBS) of the nucleus accumbens have indicated positive effects in AUD. Here we report a double-blind randomized controlled trial comparing active DBS (“DBS-EARLY ON”) against sham stimulation (“DBS-LATE ON”) over 6 months in n = 12 AUD inpatients. This 6-month blind phase was followed by a 12-month unblinded period in which all patients received active DBS. Continuous abstinence (primary outcome), alcohol use, alcohol craving, depressiveness, anxiety, anhedonia and quality of life served as outcome parameters. The primary intention-to-treat analysis, comparing continuous abstinence between treatment groups, did not yield statistically significant results, most likely due to the restricted number of participants. In light of the resulting limited statistical power, there is the question of whether DBS effects on secondary outcomes can nonetheless be interpreted as indicative of an therapeutic effect. Analyses of secondary outcomes provide evidence for this, demonstrating a significantly higher proportion of abstinent days, lower alcohol craving and anhedonia in the DBS-EARLY ON group 6 months after randomization. Exploratory responder analyses indicated that patients with high baseline alcohol craving, depressiveness and anhedonia responded to DBS. The results of this first randomized controlled trial are suggestive of beneficial effects of DBS in treatment-resistant AUD and encourage a replication in larger samples.

26 June 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SSSilvia De Santis
Silvia De Santis
ACAlejandro Cosa-Linan
Alejandro Cosa-Linan
RGRaquel Garcia-Hernandez
Raquel Garcia-Hernandez
LDLesia Dmytrenko
Lesia Dmytrenko
LVLydia Vargova
Lydia Vargova
SCSantiago Canals
Santiago Canals
The alcohol-induced inflammatory response increases the diffusion range of small molecules in the extracellular brain parenchyma.